Kyverna Therapeutics, Inc. KYTX
CIK 0001994702
Form 3 statements with an event date from Nov 1, 2023 to Nov 8, 2026.
Where insider ownership starts.
Form 3 is an initial ownership statement filed when someone becomes a reporting insider. These holdings do not mean they bought shares that day.
| Holdings date | Insider | Initial holdings | |
|---|---|---|---|
| Oct 21, 2024 | Aktar Mert Director | No securities reported | ▾ |
| Sep 16, 2024 | Biddle Warner Weston Chief Executive Officer · Director | No securities reported | ▾ |
| Sep 16, 2024 | Shaw Christi Director | No securities reported | ▾ |
| Feb 7, 2024 | Liapis Stephen Constantine Director | No securities reported | ▾ |
| Feb 7, 2024 | Liapis Stephen Constantine Director | No securities reported | ▾ |
| Feb 7, 2024 | Harper Sean E · Westlake BioPartners Fund I, L.P. · Westlake BioPartners Opportunity GP I, LLC · Westlake BioPartners Opportunity Fund I, L.P. · Westlake BioPartners GP I, LLC 10% owner / 10% owner / 10% owner / 10% owner / 10% owner | 4 derivative holdings | ▾ |
| Feb 7, 2024 | GILEAD SCIENCES, INC. 10% owner | 2 derivative holdings | ▾ |
| Feb 7, 2024 | SPIEGELMAN DANIEL K Director | 2 derivative holdings | ▾ |
| Feb 7, 2024 | Borie Dominique Christian See Remarks | 449.21K shares · 3 derivative holdings | ▾ |
| Feb 7, 2024 | CLARK IAN T Director | 3 derivative holdings | ▾ |
| Feb 7, 2024 | Cohen Fred E Director · 10% owner | 4 derivative holdings | ▾ |
| Feb 7, 2024 | Walker Karen Marie Chief Technology Officer | 3 derivative holdings | ▾ |
| Feb 7, 2024 | Chung James Bum Chief Medical Officer | 65.92K shares · 3 derivative holdings | ▾ |
| Feb 7, 2024 | Kotzin Brian L. Director | 2 derivative holdings | ▾ |
| Feb 7, 2024 | Vida Ventures, LLC 10% owner | 3 derivative holdings | ▾ |
| Feb 7, 2024 | Jones Ryan Alexander Chief Financial Officer | 25.93K shares · 5 derivative holdings | ▾ |
| Feb 7, 2024 | SEIDENBERG BETH C Director · 10% owner | 5 derivative holdings | ▾ |
| Feb 7, 2024 | Maag Peter Chief Executive Officer · Director | 2 stock holdings · 3 derivative holdings | ▾ |
| Feb 7, 2024 | Bain Capital Life Sciences Investors, LLC · Bain Capital Life Sciences Fund III, L.P. · Bain Capital Life Sciences Opportunities III, LP · Bain Capital Life Sciences III General Partner, LLC · Bain Capital Life Sciences Opportunities III GP, LLC 10% owner / 10% owner / 10% owner / 10% owner / 10% owner | 1 derivative holding | ▾ |
| Feb 7, 2024 | Rubin Michael P. · Northpond Ventures III, LP · Northpond Ventures III GP, LLC 10% owner / 10% owner / 10% owner | 1 derivative holding | ▾ |
Showing 20 / 20 statements in 2024. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For 2024, this page lists 20 of 20 statements.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_initial_holdings
{"action":"list","ticker":"KYTX","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.